Research category will give you insights on our students and staff’s achievements in research and how our research contributions benefit the society.

IMU’s Research Project Won Best Poster Award

5 Jan 2016|Programmes, Research, Staff, Students|

2-4 December 2015 - A poster presented by Dr Ramkumar Rajendran, a lecturer from the Life Sciences Department in IMU’s School of Pharmacy won the best poster award under the biopharmaceutical sciences and pharmaceutical biotechnology category at the 1st International Conference on Pharmacy Education and Research Network of ASEAN (ASEAN PharmNET1), Bangkok, Thailand. The award

Learning about Integrative Data Analyses for Systems Biology at IMU

15 Dec 2015|Research|

‘Omics platform had been frequently used in scientific research recently due to its increasing budget affordability and high data throughput. However, the majority of the subscribers in Malaysia are still dependent on external bioinformatics services for data interpretation. This had limited the scope of analyses that can be carried out (e.g. usually restricted to standard

IMU’s Researchers Awarded FRGS Grants Worth RM 495,200.00

17 Nov 2015|Research, Staff|

Four researchers from International Medical University (IMU) have been successful in securing grants under the Fundamental Research Grants Scheme (FRGS) from the Ministry of Higher Education (MOHE) this year (2015). The total amount of grants approved is RM 495,200.00. The four recipients are Dr Venkata Srikanth Meka, Dr Subrat Kumar Bhattamisra, Dr Ivan Yap Kok

IMU’s Pharmaceutical Technology Researchers Secured an Industrial Contractual Research Project

4 Nov 2015|Research|

A research team from the Department of Pharmaceutical Technology, School of Pharmacy, at the International Medical University (IMU), headed by Dr Venkata Srikanth Meka recently secured an industrial contract research agreement with InQPharm Sdn Bhd, Malaysia. InQpharm is a global life sciences-based company that develops natural healthcare products by combining science, nature and technology. With

Anti-Diabetic Drug Found to Synergise Chemotherapy in Breast Cancer Cells

1 Oct 2015|Research|

Breast cancer is a major cause of cancer-related deaths among women as controlling the recurrence and metastasis (spreading) of the disease remains a major challenge. One possible explanation is that while many cancer therapies eliminate the bulk of tumour cells, they may ultimately fail because they do not eliminate cancer stem cells (CSCs) (the original

IMU Honours its Vice President (Research) and Director of IRDI at September Convocation Ceremony

25 Sep 2015|Programmes, Research, University|

Vice President (Research) and Director of the Institute for Research, Development and Innovation (IRDI) of International Medical University (IMU), Prof Mak Joon Wah, donned his graduation gown today as he received the Honorary Doctor of Science as part of the University’s convocation ceremony on 12 September 2015. This honorary doctorate is given in recognition of his

IMU’s IRDI Successfully Organised Talk on “Managing Healthcare Costs of the Future”

7 Sep 2015|Research|

15 August 2015 - The Institute for Research, Development, and Innovation (IRDI) successfully organised a public talk on Managing Healthcare Costs of the Future under the Future of Medicine Series at the International Medical University (IMU) Bukit Jalil campus. The objective of this public talk was to raise awareness amongst the general public on the

IMU and IndiPharm Collaborate to Provide Clinical Research Training and Education

2 Sep 2015|Research|

17 August 2015 - A Memorandum of Understanding (MoU) was signed between the International Medical University (IMU) and IndiPharm (Malaysia) at the Putra World Trade Centre, Kuala Lumpur in conjunction with BioMalaysia Conference 2015. The exchange of MoU was witnessed by Yang Berhormat Datuk Wilfred Madius Tangau, Minister of Science, Technology and Innovation and Yang

IMU Organised its First Immuno-Oncology Seminar with Bioven

27 Aug 2015|Research|

13 August, 2015 - International Medical University (IMU) partnered with Bioven International Sdn Bhd to organise its first Immuno-Oncology Seminar at its campus in Bukit Jalil. Bioven is a Malaysian owned company, working on clinical trials in cancer. It is currently conducting clinical trials involving drugs against lung cancer in several countries in Europe and Asia, including

Load More Articles